Possible mechanisms for the antitumor activity of platinum coordination complexes
Rosenberg, B.
Cancer ChemoTherapy Reports 59(3): 589-598
1975
ISSN/ISBN: 0069-0112 PMID: 54213 Document Number: 94444
Document emailed within 1 workday
Related Documents
Kidani, Y.; Noji, M.; Tsukagoshi, S.; Tashiro, T. 1978: Antitumor activity of water-soluble platinum(II) complexes of 1,2-cyclohexanediamine isomers Gan 69(2): 263-265Endo, K.; Akamatsu, K.; Matsumoto, T.; Morikawa, K.; Koizumi, M.; Mitsui, H.; Koizumi, K. 1992: Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice Anticancer Research 12(1): 49-58
Mailliet, P.; Segal-Bendirdjian, E.; Kozelka, J.; Barreau, M.; Baudoin, B.; Bissery, M.C.; Gontier, S.; Laoui, A.; Lavelle, F.; Le Pecq, J.B. 1995: Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships Anti-Cancer Drug Design 10(1): 51-73
Hacker, M.P.; Khokhar, A.R.; Krakoff, I.H.; Brown, D.B.; McCormack, J.J. 1986: Water-soluble N-substituted iminodiacetato(1,2-diaminocyclohexane)-platinum(II) complexes as potential antitumor agents Cancer Research 46(12 Part 1): 6250-6254
Romanowska, K.; Kuduk-Jaworska, J. 1991: Relationship between topological properties and biological activity of platinum (II) complexes Archivum Immunologiae et Therapiae Experimentalis 39(1-2): 75-84
Saegusa, Y.; Eriguchi, M.; Kidani, Y.; Matsuzawa, A.; Takeda, Y. 2001: Antitumor effects of a new lipophilic platinum compound, trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), in mice Anticancer Research 21(1a): 245-252
Kelland, L.R.; Abel, G.; McKeage, M.J.; Jones, M.; Goddard, P.M.; Valenti, M.; Murrer, B.A.; Harrap, K.R. 1993: Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug Cancer Research 53(11): 2581-2586
Sawada, M.; Ozaki, M.; Hongo, J.; Hirota, Y.; Inagaki, M.; Taniguchi, H.; Tateishi, R.; Mori, Y. 1987: Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(3 Part 1): 693-698
Siddik, Z.H.; Thai, G.; Yoshida, M.; Zhang, Y.P.; Khokhar, A.R. 1994: Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo Anti-Cancer Drug Design 9(6): 495-509
Mulé, J.J.; Custer, M.C.; Travis, W.D.; Rosenberg, S.A. 1992: Cellular mechanisms of the antitumor activity of recombinant IL-6 in mice Journal of Immunology 148(8): 2622-2629
Das, C.; Langone, J.J. 1987: Correlation between antitumor activity of protein a and in vivo formation of defined high molecular weight complexes with immunoglobulin G in BALB/c mice Cancer Research 47(8): 2002-2007
Azuma, I. 1977: Antitumor activity and action mechanisms of BCG cell-wall skeleton and related substances Kekkaku: 52(10): 528-530
Wong, E.; Giandomenico, C.M. 1999: Current status of platinum-based antitumor drugs Chemical Reviews 99(9): 2451-2466
Kuduk-Jaworska, J. 1984: Platinum complexes as potential antineoplastic drugs Postepy Higieny i Medycyny Doswiadczalnej 38(3): 281-322
Simpkins, H.; Pearlman, L.F. 1986: Interaction of two second generation platinum antitumor drugs with mouse thymocytes Cancer Research 46(3): 1433-1439
Gale, G.R.; Atkins, L.M.; Meischen, S.J.; Smith, A.B.; Walker, E.M. 1977: Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents Cancer Treatment Reports 61(3): 445-450
Kas'ianenko, N.A.; Aĭa, E.E.; Bogdanov, A.A.; Kosmotynskaia, I.V.; Iakovlev, K.I. 2002: Comparison of DNA complexation with antitumor therapeutic cis-DDP and binuclear bivalent platinum compound containing pyrazine Molekuliarnaia Biologiia 36(4): 745-752
Schwartz, P.; Meischen, S.J.; Gale, G.R.; Atkins, L.M.; Smith, A.B.; Walker, E.M. 1977: Preparation and antitumor evaluation of water-soluble derivatives of dichloro(1,2-diaminocyclohexane)platinum(II) Cancer Treatment Reports 61(8): 1519-1525
Wright, M.; Lacorre-Arescaldino, I.; Macquet, J.P.; Daffé, M. 1984: Induction of polyploid nuclei in the plasmodium of Physarum polycephalum by platinum antitumor compounds Cancer Research 44(2): 777-783
Leopold, W.R.; Batzinger, R.P.; Miller, E.C.; Miller, J.A.; Earhart, R.H. 1981: Mutagenicity, tumorigenicity, and electrophilic reactivity of the stereoisomeric platinum(II) complexes of 1,2-diaminocyclohexane Cancer Research 41(11 Part 1): 4368-4377